This study focuses on the clinicopathological features and genomic changes in ER + /PR- breast cancers, utilizing an exclusive patient dataset from China, which includes comprehensively annotated clinical data, survival follow-up, and genomic information. The gene discussed is ESR1; the disease is breast cancer.